CB
CELG

Chemical Bank’s Celgene Corp CELG Stock Holding History

Chemical Bank’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$641K Sell
6,936
-15
-0.2% -$1.42K 0.07% 220
2019
Q1 		$656K Sell
6,951
-355
-5% -$31K 0.07% 214
2018
Q4 		$469K Sell
7,306
-1,878
-20% -$139K 0.06% 246
2018
Q3 		$822K Sell
9,184
-841
-8% -$74.3K 0.09% 199
2018
Q2 		$796K Sell
10,025
-8,792
-47% -$730K 0.09% 197
2018
Q1 		$1.68M Sell
18,817
-3,115
-14% -$299K 0.18% 123
2017
Q4 		$2.29M Sell
21,932
-26,598
-55% -$3M 0.25% 93
2017
Q3 		$7.08M Buy
48,530
+1,310
+3% +$178K 0.78% 28
2017
Q2 		$6.13M Buy
47,220
+2,433
+5% +$298K 0.67% 39
2017
Q1 		$5.57M Buy
44,787
+1,806
+4% +$216K 0.62% 38
2016
Q4 		$4.97M Buy
42,981
+2,649
+7% +$295K 0.57% 39
2016
Q3 		$4.22M Buy
40,332
+1,931
+5% +$209K 0.57% 43
2016
Q2 		$3.79M Buy
38,401
+1,585
+4% +$164K 0.52% 46
2016
Q1 		$3.69M Sell
36,816
-65
-0.2% -$6.69K 0.52% 46
2015
Q4 		$4.42M Buy
36,881
+1,023
+3% +$118K 0.62% 39
2015
Q3 		$3.88M Buy
35,858
+514
+1% +$63.8K 0.56% 46
2015
Q2 		$4.09M Sell
35,344
-863
-2% -$98.7K 0.54% 45
2015
Q1 		$4.17M Sell
36,207
-202
-0.6% -$24.1K 0.55% 46
2014
Q4 		$4.07M Buy
36,409
+630
+2% +$66.4K 0.53% 50
2014
Q3 		$3.39M Buy
35,779
+229
+0.6% +$20.7K 0.59% 41
2014
Q2 		$3.05M Buy
35,550
+780
+2% +$59.3K 0.52% 46
2014
Q1 		$2.43M Buy
34,770
+1,422
+4% +$113K 0.44% 58
2013
Q4 		$2.82M Sell
33,348
-7,820
-19% -$619K 0.5% 48
2013
Q3 		$3.17M Buy
41,168
+272
+0.7% +$19.1K 0.62% 37
2013
Q2 		$2.39M Buy
+40,896
New +$2.46M 0.47% 55

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Chemical Bank's CELG Position: Q2 2019 in Review

Chemical Bank reduced its Celgene Corp (CELG) stake by 0.22% in Q2 2019, selling an estimated $1.42K and leaving 6,936 shares worth $641K. The position accounts for 0.07% of the portfolio, ranked #220.

Chemical Bank first reported a position in CELG in Q2 2013 and has held it in 25 quarters since. The position peaked at $7.08M in Q3 2017. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Chemical Bank held 6,936 shares of Celgene Corp worth $641K as of Q2 2019.
  • Chemical Bank sold 15 Celgene Corp shares in Q2 2019, an estimated $1.42K.
  • Celgene Corp made up 0.07% of Chemical Bank's portfolio in Q2 2019, its #220 holding.
  • Chemical Bank first reported a position in Celgene Corp in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Celgene Corp position peaked at $7.08M in Q3 2017.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.